title: Use of contrast enhanced MRI in the assessment of therapeutic response to a disease-modifying antirheumatic drug. Case study of a patient with rheumatoid arthritis--6- and 24-month follow up.
authors.affiliation: Institute of Radiology, University Medical Centre, Ljubljana, Slovenia.
authors.forename: V
authors.initials: V
authors.lastname: Jevtic
authors.forename: B
authors.initials: B
authors.lastname: Rozman
authors.forename: I
authors.initials: I
authors.lastname: Watt
authors.forename: M
authors.initials: M
authors.lastname: Presetnik
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008279:Magnetic Resonance Imaging / Q000379:methods; D008662:Metacarpophalangeal Joint / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D016037:Single-Blind Method; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007555:Isoxazoles; D000077339:Leflunomide